Category:

An online pharmacy that bills itself as Canada's largest was fined $34 million...for importing counterfeit cancer drugs and other unapproved pharmaceuticals into the United States...U.S. prosecutors say Canada Drugs' business model is based entirely on illegally importing unapproved and misbranded drugs not just from Canada, but from all over the world. The company has made at least $78 million through illegal imports, including two that were counterfeit versions of the cancer drugs Avastin and Altuzan that had no active ingredient, prosecutors said...judge...approved federal prosecutors' recommended sentences that include $29 million forfeited, $5 million in fines and five years' probation for Canada Drugs...also sentenced Thorkelson (founder, Kris Thorkelson) to six months' house arrest, five years' probation and a $250,000 fine...

CVS Health is introducing a system to provide customers with greater insight into drug costs and less expensive alternatives. The plan will first be available to those using CVS' pharmacy benefit manager Caremark. Consumers are often frustrated by the difficulty of comparing the cost of treatments...CVS Health wants to make it easier for its pharmacists to find less costly drugs for patients...The drugstore chain is introducing a system that will check for less expensive alternatives, higher quantities at lower costs and discounts. CVS hopes it can help lower costs for its customers and in doing so, make sure they pick up their prescriptions...We want to be known as the retail pharmacy that does the most to help save patients money...The power of this tool, the RX Savings Finder, is we have access to the information that we need to be able to provide options to our customers to save them money...

Aurora Cannabis and CanniMed Therapeutics announced...a letter of intent to become a preferred supplier of medical cannabis to Pharmasave, member-governed cooperative of more than 650 independently owned community pharmacies...Pharmasave joins two other national pharmacy chains...These supply agreements allow...strong penetration into...a sizable portion of the medical cannabis market...pharmacists need to be prepared to fulfill their role as medication experts in the area of medical cannabis...This includes how medical cannabis may affect other medications the patient may take, any health conditions they might have and insights on how to identify and address mental health and addiction concerns in patients...

CVS Health is now planning to treat kidney failure patients, as the national drugstore chain continues to branch deeper into monitoring and providing care...it will offer home dialysis for patients through its Coram business, and it is working with another unspecified company to develop a new device for that...The companies will start a clinical trial of their device this year...CVS Health will begin its expansion into kidney care with a program that helps identify chronic kidney disease early. It will then connect those patients with nurses for training and nutritional counseling to help delay the need for dialysis...CVS Health Corp. has been broadening its reach beyond drugstores for years. It also runs a pharmacy benefit management business and is spending $69 billion to buy the insurer Aetna. It also has been expanding care offered through its more than 9,800 locations (1,100 clinics).

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

A federal judge...ordered "pharma bro" scammer Martin Shkreli to immediately pay a defrauded hedge fund investor about $388,000 in restitution, roughly half of what the investor asked for… The order comes a month after Judge Kiyo Matsumoto sentenced Shkreli to seven years in prison for defrauding that investor, Richard Kocher, and a number other people, as well as for conspiring to manipulate stock shares...In addition to his prison sentence, Matsumoto also imposed a fine of $75,000 on the 35-year-old Shkreli and ordered him to forfeit almost $7.4 million in assets to the federal government...

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Nicole Crisano, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

The Centers for Medicare and Medicaid Services has laid out a bevy of initiatives that officials said would reduce drug prices for patients covered by the Medicare Part D prescription drug program—but they have made no decisions yet...That issue is whether the discounts that pharmacy benefit managers negotiate for drugs—the “rebates” that lawmakers have been raising questions about in recent months—as well as other fees, should go toward lowering the price that a patient pays at the pharmacy...“While we are not finalizing any policy in this area at this time, we appreciate the detailed submissions from stakeholders, and we are evaluating these comments as we consider future proposals,” said CMS Administrator Seema Verma...It’s unclear whether lowering the amount of money that the patient pays at the pharmacy would actually lower the total amount of health care spending. According to an analysis by CMS that was part of the proposed rule in November, patients would indeed pay less, but the government would pay more...

Nicole Crisano, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.